Armata Pharmaceuticals, Inc.
ARMP
$1.91
-$0.10-4.98%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.69M | 9.29M | 17.14M | 26.41M | 37.86M |
| Total Receivables | 238.00K | 744.00K | 2.22M | 1.24M | 1.71M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.24M | 1.27M | 3.03M | 3.26M | 2.14M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 13.17M | 11.31M | 22.39M | 30.90M | 41.72M |
|
|
|||||
| Total Current Assets | 13.17M | 11.31M | 22.39M | 30.90M | 41.72M |
| Net Property, Plant & Equipment | 53.97M | 54.93M | 55.87M | 57.15M | 56.94M |
| Long-term Investments | 3.49M | 3.49M | 3.49M | 3.49M | 3.49M |
| Goodwill | 3.49M | 3.49M | 3.49M | 3.49M | 3.49M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.62M | 16.71M | 16.49M | 16.78M | 18.21M |
| Total Assets | 87.25M | 86.44M | 98.24M | 108.31M | 120.36M |
|
|
|||||
| Total Accounts Payable | 981.00K | 766.00K | 1.82M | 1.74M | 2.06M |
| Total Accrued Expenses | 1.98M | 3.57M | 3.48M | 3.33M | 3.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 107.24M | 43.39M | 112.40M | 117.98M | 104.17M |
| Total Finance Division Other Current Liabilities | 337.00K | 529.00K | 513.00K | 124.00K | 322.00K |
| Total Other Current Liabilities | 337.00K | 529.00K | 513.00K | 124.00K | 322.00K |
| Total Current Liabilities | 110.54M | 48.25M | 118.20M | 123.18M | 110.05M |
|
|
|||||
| Total Current Liabilities | 110.54M | 48.25M | 118.20M | 123.18M | 110.05M |
| Long-Term Debt | -- | 55.44M | -- | -- | 35.37M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 27.42M | 27.69M | 27.93M | 28.16M | 28.38M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.08M | 3.08M | 3.08M | 3.08M | 3.08M |
| Total Liabilities | 141.03M | 134.46M | 149.21M | 154.41M | 176.87M |
|
|
|||||
| Common Stock & APIC | 280.48M | 279.72M | 279.36M | 278.75M | 277.33M |
| Retained Earnings | -334.27M | -327.74M | -330.34M | -324.85M | -333.84M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -53.78M | -48.02M | -50.97M | -46.10M | -56.51M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -53.78M | -48.02M | -50.97M | -46.10M | -56.51M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -53.78M | -48.02M | -50.97M | -46.10M | -56.51M |
|
|
|||||